￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Brivaracetam original drug information and market status analysis

2026-02-01 22:25:32

Check Details
The latest news on the launch of obeticholic acid (Obeticholic) in the Chinese market in 2025

2026-02-01 22:25:32

Check Details
Comparative analysis of whether neratinib (neratinib) can replace pyrotinib treatment options

2026-02-01 22:25:32

Check Details
Will Alzheimer's disease recur after discontinuation of donanemab?

2026-02-01 22:25:32

Check Details
Is Vorasidenib suitable for patients with low-grade glioma?

2026-02-01 22:25:32

Check Details
Are common adverse reactions of Seladelpar easy to control and alleviate?

2026-02-01 22:25:32

Check Details
What are the differences in ingredients between generic drugs of Lazertinib and the original drugs?

2026-02-01 22:25:32

Check Details
Is it necessary to continue taking Bortezomib long-term after treatment?

2026-02-01 22:25:32

Check Details
Recommended regimen for combined use of Adalimumab and other drugs

2026-02-01 22:25:32

Check Details
Is Tislelizumab a PD-1 or PD-L1 inhibitor?

2026-02-01 22:25:32

Check Details
How many injections of Ustekinumab are required a year?

2026-02-01 22:25:32

Check Details
What are the formal purchase channels for Tarlatamab in the country?

2026-02-01 22:25:32

Check Details
Category
相关知识